Press Releases
We’re Delivering the Promise of Healthier Lives.
CURE PHARMACEUTICALÂ
Press Releases
We specialize in optimal formulations to achieve targeted release and exposure of medications.​
CURE Pharmaceutical Expands Cannabis Extraction Patents, Adding Support for CBG for Therapeutic Solutions
Equipment manufacturers, cannabis processors and drug developers can license CURE
CURE Pharmaceutical Secures Chinese Patent on its Oral Thin Films to Treat Erectile Dysfunction
ED Drug Market Expected to Reach US$6.5B by 2025 OXNARD, Calif., March 17, 2020 (GLOBE NEWSWIRE) — CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the allowance of Chinese Patent No. ZL201480039313.6. The new patent covers the loading of high amounts of active drug on an oral thin film using its […]
CURE Pharmaceutical Licenses Cannabis Extraction Patents to Vanguard Scientific
Vanguard Scientific builds customer trust with CUREinside
CURE Pharmaceutical Expands to Europe, Signs Licensing Agreement with ReLeaf Europe to Provide Advanced Cannabinoid Delivery
CURE debuts
CURE Pharmaceutical to Present at the 12th Annual LD Micro Main Event Investor Conference
CURE CEO to discuss company
CURE Pharmaceutical Names Canopy Rivers
Industry veteran brings 40 years of experience to support CURE
CURE Pharmaceutical Takes First Step to Acquire Coeptis Pharmaceuticals and its Combination Drug for Osteoarthritis Pain and Hypertension
OXNARD, Calif., November 14, 2019
CURE Pharmaceutical Debuts CUREform Drug Delivery Line Adding Chewables and Emulsions
Alternative dosage demand drives company
CURE Pharmaceutical Promotes Dr. Vered Gigi to Chief Scientific Officer
Biopharma star brings extensive translational research experience as company advances its clinical indications Oxnard, Calif.
CURE Pharmaceutical Takes First Step To Secure Hemp CBD Supply Chain by Partnering with Fytiko Farms
OXNARD, Calif.
CURE Pharmaceutical Expands Board with Two Women Directors
Oxnard, Calif.
CURE Pharmaceutical Secures Patent on High Loading of Active Ingredient in Oral Thin Films
OXNARD, Calif.
CURE Pharmaceutical Secures Patent on Oral Thin Films With Bi-Phasic Release of Natural Ingredients
OXNARD, Calif.
CURE Pharmaceutical and Canopy Growth To Produce CBD Oral Thin Films
OXNARD, Calif.
CURE Pharmaceutical to Present at the 9th Annual LD Micro Invitational
LOS ANGELES, May 30, 2019 (GLOBE NEWSWIRE) — CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that it will be presenting at the 9th Annual LD Micro Invitational on Wednesday, June 5th at 11:40 a.m. PT at the Luxe Sunset Boulevard Hotel in Los Angeles. The conference will be held on June 4-5, 2019. […]
CURE Pharmaceutical Secures Patent on Oral Thin Film Containing Bioactive Cannabinoid Molecules
OXNARD, Calif.
CURE Pharmaceutical Expands Leadership Team with Key New Hires
OXNARD, Calif., May 20, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced the addition of four key hires to their growing leadership team. Michael Redard will serve as CURE's Chief Financial...
CURE Pharmaceutical Closes Acquisition Of Privately-Held Chemistry Holdings Inc.
Acquired Technology Expands Core CUREfilm
Meroven LLC and CURE Pharmaceutical Enter Exclusive Marketing and Distribution Agreement for Spee-D for the USA
CHICAGO
CURE Pharmaceutical Extends Closing Of Privately-Held Chemistry Holdings Inc. Acquisition to May 13
OXNARD, Calif., May 01, 2019 (GLOBE NEWSWIRE) — CURE Pharmaceutical (OTC: CURR) (
CURE Pharmaceutical to Present at the Planet Microcap Showcase 2019
CURE CEO to discuss expanded product pipeline and company
CURE Pharmaceutical Named
OXNARD, Calif., April 26, 2019 (GLOBE NEWSWIRE) — CURE Pharmaceutical (OTC: CURR) (
Uptick Newswire Hosts CURE Pharmaceutical on The Stock Day Podcast to Discuss Major Milestones and 2019 Goals
PHOENIX, AZ / ACCESSWIRE / April 16, 2019 / Uptick Newswire Stock Day Podcast welcomed CURE Pharmaceutical (OTCQB: CURR) (”the Company”), a vertically integrated drug delivery and development company committed to improving drug efficacy, safety and the patient experience through its proprietary drug dosage forms and delivery systems. CEO Rob Davidson joined Stock Day host Everett Jolly. To […]
United Smart Cities and Cure Pharmaceutical Launch Global Healthcare Awareness Initiative
LOS ANGELES, April 9, 2019
CURE Pharmaceutical to Acquire Privately-Held Chemistry Holdings Inc., Expanding Its Technology Platform in Oral Drug Delivery
** For FREQUENTLY ASKED QUESTIONS regarding this announcement, please click here to read FAQs ** OXNARD, Calif., April 1, 2019